oxymetazoline has been researched along with Cardiac Failure in 1 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forster, C | 1 |
| Campbell, PM | 1 |
| Armstrong, PW | 1 |
1 other study available for oxymetazoline and Cardiac Failure
| Article | Year |
|---|---|
Temporal alterations in peripheral vascular responsiveness during both the development and recovery from pacing-induced heart failure.
Topics: Adrenergic alpha-Agonists; Animals; Arteries; Azepines; Cardiac Pacing, Artificial; Dinoprost; Dogs; | 1992 |